The global cartilage repair
market is witnessing considerable growth due to increasing
geriatric population, increasing obesity, increasing healthcare expenditure, and
growing sports related injuries. Moreover, increase in innovative product
launches and growth of medical tourism leading to awareness about the cartilage
treatment modalities across the globe is supporting the growth of the market. Based
on the treatment modalities, cell-based approaches segment is expected to grow
at the fastest rate during the forecast period, due to long term results of this
treatment.
Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/cartilage-repair-market/report-sample
The rapid growth in emerging economies and technological advancement
in cartilage repair and regeneration products is expected to create
opportunities for the manufacturers of cartilage repair products across the
globe. However, the high cost of these products and lack of reimbursement for
these treatments are the key factors hampering the growth of the global market.
Obesity is a serious health concern in the U.S. The increasing
prevalence of obesity is driving the growth of the cartilage repair market in
the U.S. According to CDC, during 2011-2012, 35.1% of adult aged 20 years or
above were obese. In addition, as published by the Organization for Economic
Cooperation and Development (OECD) in the year 2014, the obesity rate in
Germany increased from 11.5% in 1999 to 14.7% in 2009. This increase in obesity
rate leads to increase in demand for liposuction procedures, which is further
accelerating the market growth.
The key players operating in the global cartilage repair market are Zimmer
Biomet Holdings, Inc., Johnson & Johnson, Vericel Corporation, Smith &
Nephew PLC, Osiris Therapeutics, Inc., RTI Surgical, Conmed Linvatec, B. Braun
Melsungen AG, Anika Therapeutics S. R. L. and Arthrex, Inc.
No comments:
Post a Comment